SCHEMBL17034338

SCHEMBL17034338

C=C(C)C(=O)OCCCCCNC(=O)OCCc1ccc(OCC(O)COC(=O)NCCCCCOC(=O)C(=C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
POLB P06746 2/20 0.47
APEX1 P27695 1/20 0.47
HTT P42858 1/20 0.47
ADRB2 P07550 3/20 0.40
ADRB1 P08588 3/20 0.40
ADRB3 P13945 2/20 0.40
ABCB1 P08183 1/20 0.39
PLA2G4B P0C869 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
PMP22 Q01453 1/20 0.38
NR3C1 P04150 1/20 0.38
CYP2D6 P10635 1/20 0.38
ADRA1A P35348 1/20 0.38
CYP2J2 P51589 1/20 0.38
PDE4D Q08499 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034215 0.99 TDP1 (0.47) TDP1POLBAPEX1HTTADRB2
SCHEMBL17034279 0.96 TDP1 (0.43) TDP1POLBAPEX1HTTADRB2
SCHEMBL17034222 0.95 TDP1 (0.44) TDP1POLBAPEX1HTTADRB2
SCHEMBL17034274 0.92 ABCB1 (0.41) TDP1POLBAPEX1HTTADRB2
SCHEMBL17034214 0.91 ABCB1 (0.42) TDP1POLBAPEX1HTTADRB2
SCHEMBL17034362 0.89 POLB (0.56) TDP1POLBAPEX1HTTMAPT
SCHEMBL17034226 0.89 POLB (0.56) TDP1POLBAPEX1HTTMAPT
SCHEMBL17034244 0.86 POLB (0.53) TDP1POLBAPEX1HTTLMNA
SCHEMBL17034358 0.86 POLB (0.53) TDP1POLBAPEX1HTTLMNA
SCHEMBL17034354 0.85 THRB (0.39) TDP1ADRB2ADRB1ADRB3ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015126666-A1 DENTAL COMPOSITION AND USE THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-08-27 WO disclosed